On Jan. 11, 2021, TheNew York Times posted an article about the virtues of fecal immunochemical testing relative to colonoscopy. The story, “A Colonoscopy Alternative Comes Home” [https://www.nytimes.com/ 2021/ 01/ 11/ health/ colonoscopy-health-home-testing.html] depicted colonoscopy as a comparatively risky procedure with few advantages over less invasive methods of testing for colorectal cancer. It also offered the speculation that financial factors— namely, greater reimbursement for endoscopy—was behind the general preference of gastroenterologists for colonoscopy over stool tests.
Trending
- ‘A slippery slope’: Is AI eroding clinical skills? (Healio)
- ModMed Expands gGastro Suite With New AI Capabilities for Gastroenterology (Business Wire)
- CRH Anesthesia Announces Partnership with Associates in Gastroenterology Through Acquisition of Majority Interest in Southern Colorado Anesthesia Associates (CRH Medical)
- Bidirectional Text Navigation (ColoPrep) Increases Colonoscopy Show Rate (Gastro Hep Advances)
- Viome Launches CancerDetect® Pancreatic, Built For Early Pancreatic Cancer Detection (PR Newswire)
- Magnetically controlled capsule shows promise for investigating hard-to-reach regions of the small intestine (Medical Xpress)
- Successful Repeat Colonoscopy and Building an AI Databank (GI & Endoscopy News)
- What created GI’s anesthesia ‘dependency’ — and what comes next (Becker’s Healthcare)
